WFSBP Programme 2015

Monday, 15 June 2015

Scientific Programme

WFSBP 2015

P-02-017

Parental history of psychiatric diagnoses and unipolar de-

pression: A Danish national register-based cohort study

Trine Munk-Olsen, Denmark

K. L. Musliner, B. Trabjerg, B. Waltoft, T. Munk Laursen, P.

B. Mortensen

P-02-018

Serum igG response to 43 food antigens in major depres-

sion indicates lower igG response to dairy proteins in de-

pressed patients

Agata Szulc, Poland

L. Rudzki, D. Pawlak, N. Waszkiewicz, A. Malus, M. Galecka,

P. Szlachta, B. Konarzewska

P-02-019

Aerobic exercise as add-on treatment improves alertness

and working memory in depressed patients: Preliminary

results from a randomized controlled multicentre-trial

Christian Imboden, Switzerland

J. Beck, M. Gerber, U. Pühse, E. Holsboer-Trachsler, M. Hat-

zinger

P-02-020

Androgen receptor increases resistance to depressive-like

phenotypes in chronic unpredictable mild stress through

maintaining brain-derived neurotrophic factor

Yi-Yung Hung, Taiwan

P-02-021

Cortical inhibition in the pathophysiology and treatment

of major depressive disorder

Daphne Voineskos, Canada

A. Levinson, D. Blumberger, Z. J. Daskalakis

P-02-023

Association between plasma brain-derived neutrophic fac-

tor levels and impulsiveness in recent suicide attempters

Livia Ambrus, Sweden

Å. Westrin

P-02-024

Factors associated with suicide completion: A comparison

between suicide attempters and completers

Woong Hahm, Republic of Korea

S. H. Joo, I. H. Paik

P-02-025

A comparative study of permissive attitudes toward sui-

cide in South Korea, Japan, and the U.S.: A cross-national

analysis

Hyeyoung Kim, Republic of Korea

B. Kim, S. S. Lee, C.-j. Baek, Y.-M. Ahn

P-02-026

The impact of alcohol problems on depressive symptoms

Masaya Tayama, Japan

M. Yamamoto, T. Saito

P-03

Poster Presentation

12:45–14:15

Muses Foyer

Schizophrenia/Dementia

Chair:

Charalambos Touloumis, Greece

Co-Chair: Thomas Matsoukas, Greece

P-03-002

Cerebrospinal fluid and plasma concentrations of

Non-Phosphorylated Tau protein as a novel potential bio-

marker of Alzheimer‘s disease

Piotr Lewczuk, Germany

N. Lelental, I. Lachmann, A. Perret-Liaudet, J. Kornhuber

P-03-003

Aberrant gray matter structure associated with sleep distur-

bance in the drug naïve subjects with Alzheimer‘s disease

Soo Hyun Joo, Republic of Korea

J. Y. Nam, H. K. Lim, I. H. Paik, W. Hahm, C. U. Lee

P-03-004

Development of Abeta42 surrogate marker in peripheral

blood

Shinji Tagami, Japan

S. Sano, K. Yanagida, T. Kodama, N. Mizuta, T. Tomonaga,

M. Takeda, M. Okochi

P-03-005

Exploring the effect of adducins genetic variability on cog-

nition in schizophrenia

Alessandro Pigoni, Italy

M. Bosia, L. Zagato, N. Casamassima, C. Lorenzi, A. Piro-

vano, M. Spangaro, E. Smeraldi, P. Manunta, R. Cavallaro

P-03-006

Functional genetic and epigenetic analyses reveal rare mu-

tations and hypermethylation of the ARC associated with

schizophrenia

Yang-An Chuang, Taiwan

M.-C. Cheng, T.-M. Hu, C.-H. Chen, S.-H. Hsu, H.-Y. Tsai

P-03-007

Oxidative stress and treatment response in schizophrenia:

Acute relpase and chronic stable stage

Yi-Ling Chien, Taiwan

C.-M. Liu, S.-Y. Lin-Shiau, H.-G. Hwu

P-03-008

PET study of thalamic dopamine D2-receptors in drug-naive

patients with schizophrenia

Pauliina Ikonen, Sweden

S. Cervenka, K. Collste, H. Fatouros-Bergman, G. Matheson,

P. Plaven Sigray, A. Varrone, C. Halldin, L. Flyckt, L. Farde